Natto enzyme may lower heart risk in high cholesterol patients
NCT ID NCT06183307
First seen May 15, 2026 · Last updated May 16, 2026 · Updated 1 time
Summary
This study tests whether nattokinase, an enzyme from fermented soy (natto), can reduce inflammation and improve heart health markers in people with high cholesterol. About 48 adults with dyslipidemia will take nattokinase or a placebo for two months. Researchers will measure changes in blood markers like C-reactive protein and cholesterol to see if the supplement helps control disease risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Denise Mafra
RECRUITINGRio de Janeiro, Rio de Janeiro, 22260050, Brazil
Contact
Conditions
Explore the condition pages connected to this study.